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Abstract Hemophilia is a rare genetic bleeding disorder associated with pain, impaired
functionality, and decreased quality of life (QoL). Several studies have focused on
patient-reported outcomes of people with hemophilia (PWH) worldwide, but no such
data are available for Portugal. This survey aimed to describe sociodemographic,
clinical, and psychosocial characteristics of PWH of all ages in Portugal. Questionnaires
were answered by self-report or by parents of children with hemophilia (proxy version).
Variables assessedwere sociodemographic and clinical, physical activity patterns, pain,
functionality (HAL/PedHAL), QoL (A36 Hemoﬁlia-QoL/CHO-KLAT), anxiety and depres-
sion (PROMIS), and illness perceptions (IPQ-R). One-hundred and forty-six PWH
answered the survey: 106 adults, 21 children/teenagers between 10 and 17 years,
11 children between 6 and 9 years, and 8 children between 1 and 5 years. Most
participants had severe hemophilia (60.3%) and type A was most commonly reported
(86.3%). Bleeding episodes, joint deterioration, and pain were very prevalent, with the
ankles and knees being the most affected joints, as illustrated by HAL/PedHAL scores.
The A36 Hemoﬁlia-QoL assessment showed moderate QoL (96.45; 0–144 scale) and
signiﬁcant anxiety and depression symptoms were found in 36.7 and 27.2% of adults,
respectively. CHO-KLAT global score (0–100 scale) was 75.63/76.32 (self-report/
proxy). Concerning hemophilia-related illness beliefs, a perception of chronicity and
symptoms unpredictability was particularly prominent among adults and children/
teenagers. This survey provided a comprehensive characterization of Portuguese PWH,
including the ﬁrst report of psychosocial characteristics. The ﬁndings allow for a deeper
understanding of life with hemophilia in Portugal and the identiﬁcation of relevant
health care and research needs.
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Introduction
Hemophilia is a rare and lifelong genetic bleeding disorder
linked to the X-chromosome, which is caused by a deﬁciency
of clotting factor, more speciﬁcally factor VIII (hemophilia A)
or IX (hemophilia B).1 The severity of hemophilia depends on
clotting factor level and is classiﬁed accordingly as mild
(clotting factor between 5 and 40% of normal), moderate
(1–5% of normal clotting factor), or severe (clotting factor
level <1% of normal).2 The main clinical manifestation is an
increased bleeding tendency, either spontaneous or related
to trauma or surgery. Spontaneous bleeding episodes occur
most often in the joints (hemarthrosis) and, if recurrent,
might lead to hemophilic arthropathy, characterized by joint
deformity, disability and chronic pain, and responsible for a
variable degree of impairment and limitations in daily living,
that can ultimately lead to the need for orthopaedic surgery.3
Clotting factor replacement therapy, aiming to increase
deﬁcient factor levels, is the mainstay in hemophilia treat-
ment, either delivered on demand (to treat a bleed after its
occurrence) or prophylactically (regularly, to prevent
bleeds). However, while regular prophylaxis since childhood
is the recommended standard of care for bleeding prevention
and related complications, its widespread adoption is hin-
dered by a very high cost.1,4–6 As early prophylaxis is
relatively recent in developed countries, and still not widely
accessible in developing countries, most adult PWH already
present damaged joints due to the lack of prophylactic
treatment in their infancy.7 Yet, spontaneous bleeding can
still happen in children under prophylaxis and trauma-
related bleeds cannot be at all prevented.8 In addition,
development of alloantibodies against replacement factor
VIII or IX (inhibitors) rises another serious problem, by
limiting treatment options and consequently leaving
patients at greater risk for hemarthrosis and hemophilic
arthropathy.1
Several studies have shown that hemophilia has a nega-
tive impact on quality of life (QoL), which is often lower
among PWH, when compared with the general popula-
tion.9,10 Actually, current guidelines for optimal hemophilia
care recognize the relevance of QoL and establish psychoso-
cial health promotion as a priority in the care of PWH, along
with the prevention of bleeds and management of complica-
tions.5 Therefore, QoL should be routinely monitored in
clinical practice, as part of patient care and as a complement
to objective clinical measures, though this is rarely done in
most European centers.11
In an effort to address psychosocial issues, several hemo-
philia-speciﬁc questionnaires have been developed (e.g., QoL
indexes and activity scores), with numerous investigations
focusing on the assessment of patient-reported outcomes
(PROs) of PWH worldwide.12,13 With the advances in avail-
able treatments and improved illness control for younger
generations, there is an increased interest in the assessment
of PROs. As a matter of fact, these are more sensitive and
reliable indicators of the impact of hemophilia and the
effectiveness of treatment, thus allowing to complement
objective clinical assessment with the patient’s perspective.5
However, despite the amount of investigations centered on
these issues, no such data have been comprehensively
assessed and reported in Portugal, wherein there is an
estimated prevalence of 700 cases of hemophilia.14
The purpose of this investigation is to provide a compre-
hensive joint description of sociodemographic, clinical, and
psychosocial characteristics of PWH in Portugal, to ﬁll an
important gap on such knowledge. This is particularly rele-
vant in chronic conditions such as hemophilia that are
associated with signiﬁcant disability, demanding lifelong
treatments and high health care costs. Therefore, assessing
patients’ perspectives on illness symptoms, psychosocial
impact and treatment effectiveness is crucial to inform
physicians and policymakers toward the improvement of
comprehensive health care policies.7
Material and Methods
Design
This is a cross-sectional observational study among PWH
registered in the Portuguese Haemophilia Association (APH).
An envelope containing an invitation to participate and the
description of study objectives, in addition to the informed
consent and the questionnaires, was sent by mail to a total
of 500 male persons registered in APH as having hemo-
philia. The surveys were sent in October 2016 and received
until May 2017. A telephone call was made to all PWH who
had not sent the survey after 3 months (January 2017), both
as a reminder and as a mean to clarify possible doubts.
Approval for this study was obtained by the Ethical Com-
mittee at University of Minho and by the Portuguese Data
Protection Agency, and it is registered at clinicaltrials.gov
(NCT02870114). Informed consent was obtained from the
participants or legal guardians.
Participants and Procedure
Participants included in this survey were male PWH with
hemophilia A or B of all ages. Exclusion criteriawere inability
to read and write or to consent voluntary participation.
To comprehensively assess PWH of all ages, four similar
but age-appropriate versions were developed, varying
according to target age (adults vs. teenagers and children)
andmode of response (self-report vs. proxy): (1) adults (self-
report)—  18 years old; (2) children/teenagers (self-report)
—from10 to 17 years old; (3) parents (proxy version)—from6
to 9 years old; and (4) parents (proxy version)—from 0 to
5 years old. Survey content was based on an extensive
literature review focused on studies and surveys conducted
with PWH worldwide, being further discussed in meetings
with medical experts and later reﬁned to guarantee rele-
vance and avoid repetition and respondents exhaustion. The
resulting versions were submitted to pilot testing with six
adults and six children/teenagers with hemophilia, and four
parents/caregivers for comments on content, wording, and
length. This process resulted in additional modiﬁcations
until a ﬁnal form was reached for each survey version. The
variables and questionnaires included in each version are
summarized in ►Table 1 and a more detailed description of
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the instruments can be found in the following section.
Questionnaires that were not yet adapted to European
Portuguese (A36 Hemoﬁlia-QoL, CHO-KLAT, HAL, and Ped-
HAL) underwent a complete translation–back translation
process followed by pilot testing.
Data Collection
• Sociodemographic and Clinical Questionnaires: gather
information on sociodemographic (e.g., age, education,
household, professional status) and clinical (e.g., disease
type and severity, inhibitor status, factor replacement
consumption, bleeding episodes) characteristics.
• Physical Activity Questionnaire: collects information
about physical activity and sports participation.
• Pain Questionnaire: assesses hemophilia-related pain
through a set of questions regarding duration, frequency,
location, and impact.
• A36 Hemoﬁlia-QoL:15 evaluates hemophilia-speciﬁc QoL
through 36 items, according to 9 subscales: physical
health, daily activities, joints, pain, treatment satisfaction,
treatment difﬁculties, relationships and social activity,
emotional functioning, andmental health. Global QoL raw
score ranges between 0 and 144, with higher values
indicating better QoL. A percentile score can also be
computed (0–100 percentile) for the global scale and
each of the dimensions.
• Canadian Haemophilia Outcomes-Kids' Life Assessment
Tool (CHO-KLAT):16 measures hemophilia-speciﬁc QoL in
children and teenagers through 35 items, which can be
answered by the child/teenager with hemophilia or by a
proxy (parent version). The total score is presented on a 0
to 100 scale, with a value of 100 being the best possible
QoL.
• Haemophilia Activities List (HAL):17 evaluates patients’
self-perceived functional ability, namely, the difﬁculty in
performing activities due to hemophilia. It has 42 items
and is divided in 7 subscales: lying/siting/kneeling/
standing, function of the legs, function of the arms,
use of transportation, self-care, household tasks, and
leisure activities and sports. A normalized score can be
computed for each dimension and for the global scale,
ranging from 0 (worst functional status) to 100 (best
functional status).
• Pediatric Haemophilia Activities List (PedHAL):18 this is
an adaptation of the above-mentioned HAL for use with
children and teenagers, assessing the same dimensions
with 53 items, but with some adjustments to younger
ages. A proxy version is also available, to be answered by
parents or caregivers. Similarly with HAL, the raw score
for each domain is converted to a normalized score, with 0
representing the worst and 100 the best possible func-
tional status.
• PROMIS-Anxiety and Depression (version 1.0):19 each
measure has four items that assess symptoms of anxiety
and depression such as fear (anxiety) or hopelessness
(depression). Scores range from4 to 20, with higher scores
indicating more severe symptoms. A score of 8 has been
proposed as the cut-off for clinically relevant symptoms in
both scales.20
• Illness Perception Questionnaire-Revised (IPQ-R):21
evaluates illness perceptions and beliefs about hemo-
philia through 21 items, divided in 7 dimensions: time-
line acute/chronic, timeline cyclical, consequences,
personal control, treatment control, illness coherence,
and emotional representation. Scores vary between 3
and 15 and higher values translate more threatening
illness perceptions.
Table 1 Survey versions, variables, and questionnaires
Variables Measures Adults
Age  18 y
Children/
Teenagers
Age 10–17 y
Children
Age 6–9 y
Children
Age 1–5 y
Self-Report Proxy
Sociodemographic Sociodemographic questionnaire U U U U
Clinical Clinical questionnaire U U U U
Physical activity and sports Physical activity questionnaire U U U U
Pain Pain questionnaire U U U U
Quality of life A36 Hemoﬁlia-QoL U – – –
CHO-KLAT – U U –
Functionality HAL U – – –
PedHAL – U U –
Emotional distress PROMIS Anxiety U – – –
PROMIS Depression U – – –
Illness perceptions IPQ-R U U – –
Abbreviations: CHO-KLAT, Canadian Haemophilia Outcomes-Kids' Life Assessment Tool; HAL, Haemophilia Activities List; IPQ-R, Illness Perception
Questionnaire-Revised; PedHAL, Pediatric Haemophilia Activities List; PROMIS, Patient-Reported Outcomes Measurement Information System.
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Data Analysis
Data analysis was conducted using the IBM SPSS version 24
software (Chicago, Illinois, United States). Data were ana-
lyzed using frequencies and are described as n (%). Contin-
uous variables are presented as mean (M) and standard
deviation (SD) and/or median (Md) and range.
Results
Return Rate
Of the 500 surveys sent, 146 were returned by participants
(29.2% response rate). Although participants were reminded
through telephone call, it was not possible to reach to all
PWH. ►Fig. 1 shows a ﬂowchart where reasons associated
with nonparticipation are described. Respondents were not
signiﬁcantly different from nonrespondents in terms of age.
Demographic Characteristics
Among the 146 participants, 106 (72.6%) were adults (mean
age ¼ 43.49; SD ¼ 13.89), 21 (14.4%) children/teenagers
between 10 and 17 years old (mean age ¼ 14.00; SD ¼ 2.39),
11 (7.5%) children between 6 and 9 years old (mean age
¼ 7.73; SD ¼ 1.01), and 8 (5.5%) children between 1 and
5 years old (mean age ¼ 3.38; SD ¼ 1.60). All participants
were of Portuguese nationality. Concerning geographic dis-
tribution, 62 (42.5%) participants were from the north of the
country, 38 (26%) from the center, 43 (49.2%) from the south,
and 10 (6.9%) from the autonomous regions (results not
shown).
All respondents in the proxy version were parents (mean
age: 39.47; SD ¼ 5.99), the majority being the mother (17;
89.5%). Most parents were married (15; 78.0%), 3 (15.8%)
were single, and 1 (5.3%) was divorced (results not shown).
Further sociodemographic characteristics of study respon-
dents are summarized in ►Table 2.
Impact of Hemophilia on Employment, Education, and
Economic Issues
►Table 2 shows that 57 (53.7%) adults had a professional
activity and 38 (35.8%) were unemployed, retired, or on
medical leave. About half (20; 52.6%) of the participants in
this latter situation stated it was due to hemophilia. Among
the adult participants who had an occupation, either a full or
a part-time job, or a student status, 28 (42.4%) reported
missed days from work or school due to hemophilia
(M ¼ 28.57; SD ¼ 55.67) and of those on a full or a part-
Fig. 1 Flowchart of study participants and reasons for nonparticipation. 1Other reasons for nonparticipation included living abroad (n ¼ 6),
unable to answer due to other comorbidities (blindness, cerebral palsy, and cognitive impairment) (n ¼ 3), bad phone reception despite several
calls (n ¼ 3), and increased factor activity level (>40%) due to liver transplant (n ¼ 2).
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Table 2 Sociodemographic information of survey respondents
Adults
 18 y
N ¼ 106
Children/
Teenagers
10–17 y
N ¼ 21
Children (proxy version)
6–9 y
N ¼ 11
1–5 y
N ¼ 8
Age 43.49 (13.89)
Md ¼ 44
range: 18–74
14.00 (2.39)
Md ¼ 14
range: 10–17
7.73 (1.01)
Md ¼ 8
range: 6–9
3.38 (1.60)
Md ¼ 3.50
range: 1–5
Education (completed level)
Primary school (1st–4th grade) 6 (5.7%) 12 (57.1%) – –
Middle school (5th–9th grade) 25 (23.6%) 9 (42.9%) – –
High school (10th–12th grade) 40 (37.7%) – – –
College degree 29 (27.3%) – – –
Postgraduate degree 5 (4.7%) – – –
Marital status
Single 37 (34.9%) – – –
Married 61 (57.5%) – – –
Divorced/separated 4 (3.8%) – – –
Widower 1 (0.9%) – – –
Professional status
Student 9 (8.4%) 21 (100%) 10 (90.9%) –
Full or part-time job 57 (53.7%) – – –
Unemployed 8 (7.5%) – – –
Retired 28 (26.4%) – – –
Medical leave 2 (1.9%) – – –
If unemployed/retired/medical leavea N ¼ 38
Due to hemophilia 20 (52.6%) – – –
Perceived impact of hemophilia on workb N ¼ 57
No impact 28 (49.1%) – – –
Little impact 17 (29.8%) – – –
Some impact 9 (15.8%) – – –
High impact 3 (5.3%) – – –
Very high impact 0 – – –
Work/school/kindergarten absences due
to hemophiliac
N ¼ 66
28 (42.4%)
N ¼ 21
12 (57.1%)
N ¼ 10
8 (80.0%)
N ¼ 7
6 (85.7%)
Number of days missed
last year
28.57 (55.67)
Md ¼ 15
range: 1–293
5.58 (4.46)
Md ¼ 3.5
range: 1–15
8.50 (9.20)
Md ¼ 4.5
range: 2–30
8.83 (10.76)
Md ¼ 4
range: 2–30
Household income
 530€ 11 (10.4%) 1 (4.8%) 1 (9.1%) 0
531€–1,060€ 25 (23.6%) 4 (19.0%) 1 (9.1%) 1 (12.5%)
1,061€–2,120€ 41 (38.8%) 10 (47.6%) 5 (45.5%) 6 (75.0%)
 2,121€ 13 (12.3%) 2 (9.6%) 2 (18.2%) 0
Decline to answer 14 (13.2%) 3 (14.3%) 2 (18.2%) 1 (12.5%)
Perceived impact of hemophilia on
ﬁnances
No impact 44 (41.5%) – – –
Little impact 26 (24.5%) – – –
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time job, 29 (50.9%) indicated an impact of hemophilia on
their professional activity. Most children and teenagers from
the 10 to 17 (12; 57.1%), 6 to 9 (8; 72.7%), and 1 to 5 (6; 85.7%)
age groups also reportedmissed days from school. Moreover,
58 (54.6%) adults pointed to an impact of hemophilia on their
economic situation (ﬁnances).
Most parents answering the proxy versionswere employed
(13; 68.5%) and 4 (21.1%) were unemployed. From the latter,
three (75%) considered that they were in that situation due to
their child’s hemophilia. Fifteen parents (79%) reported that
the time dedicated to their professional activity is limited by
hemophilia (no impact: 3 [15.8%]; little impact: 9 [47.4%]; high
impact: 4 [21.1%]; veryhigh impact: 2 [10.5%]), and9 (60%)had
missed days from work (M ¼ 9.89; SD ¼ 11.68) to assist the
child in issues related to hemophilia (results not shown).
Clinical Characteristics
►Table 3 reveals that most participants in all four age groups
had hemophilia A, with severe hemophilia being the most
commonly reported (see ►Table 3 for comparison between
age groups). Prophylaxis treatment was reported by 35 (33%)
adults, 16 (76.2%) children/teenagers, 9 (81.8%) children
between 6 and 9 years, and 4 (50%) children between 1
and 5 years. The occurrence of bleeding episodes in the
previous year was reported by 71 (67%) adults, 15 (71.4%)
children /teenagers, and 6 (54.5%) and 4 (50%) young chil-
dren, with the mean number of bleeding episodes varying
from 4.53 (SD ¼ 3.36) in the group of children/teenagers to
14.94 (SD ¼ 16.90) among adults.
►Table 3 also gives information on joint deterioration and
number of affected joints, showing that most adults (72;
67.9%) reported at least a joint that was most affected as a
result of hemophilia. This speciﬁc outcome was less pointed
out by younger groups (10–17 years: 8 [38.1%]; 6–9 years: 3
[27.3%]; 1–5 years: 0). Further disease and treatment char-
acteristics are detailed in ►Table 3, such as information
regarding type of factor concentrate, inhibitors status, urgent
hospital visits, and hospitalizations due to hemophilia.
Finally, ►Table 3 exhibits information about pain due to
hemophilia, showing that in the previous year pain was
reported by a vast majority of participants of all age groups
(18 years: 82 [77.4%]; 10–17 years: 16 [76.2%]; 6–9 years: 9
[81.8%]; 1–5 years: 4 [50%]). Pain in the lower limbs was
considered to have the greatest impact, namely, in the ankles
(18 years: 31 [37.8%]; 10–17 years: 7 [43.9%]; 6–9 years: 5
[55.5%]; 1–5 years: 1 [25%]). Pain showed a wide duration
range, varying from 1 month in three age groups to 612
months (51 years) in the adults group.
Physical Activity and Sports
As shown in ►Table 4, the practice of regular physical
activity was reported by 29 (27.4%) adults, 12 (57.1%)
children/teenagers, 9 (81.8%) children in 6 to 9 years group,
and 4 (50%) children in 1 to 5 years group. In addition to the
performance of a regular activity, participants also indicated
an activity or sport which they would like to practice, but
could not due to hemophilia. Swimming was the most
practiced regular physical activity among all age groups,
whereas football was the ﬁrst aspired sport among all age
groups. Further details on regular and aspirational activities
and sports are described in ►Table 4.
Quality of Life and Functionality
Regarding QoL, ►Table 5 shows that A36 Hemoﬁlia-QoL
global mean score was 96.45 (SD ¼ 27.33), with subscale
scores for each speciﬁc domain also being reported. Con-
sidering CHO-KLAT, mean scores were 75.63 (SD ¼ 12.06)
for the 10 to 17 years old group and 76.32 (SD ¼ 11.89) for
the 6 to 9 years old group.
Results from HAL and PedHAL are also presented
in ►Table 5 revealing that, in what concerns functionality,
PWH of all ages had the lowest scores on “Functions of the
legs.” Adults reported better functioning in “Self-care”
(M ¼ 80.69; SD ¼ 22.89), while children/teenagers had the
highest scores on “Household tasks” (M ¼ 96.83; SD ¼ 7.19)
and children in 6 to 9 years old group reported less difﬁcul-
ties in “Functions of the arms” (M ¼ 91.52; SD ¼ 20.99).
Emotional Distress
Mean scores of psychological distress were 7.02 (SD ¼ 2.95)
for anxiety and 6.23 (SD ¼ 3.26) for depression (►Table 5).
Considering the proposed cut-off scores of 8 for clinically
Table 2 (Continued)
Adults
 18 y
N ¼ 106
Children/
Teenagers
10–17 y
N ¼ 21
Children (proxy version)
6–9 y
N ¼ 11
1–5 y
N ¼ 8
Some impact 16 (15.1%) – – –
High impact 8 (7.5%) – – –
Very high impact 8 (7.5%) – – –
Note: Continuous variables are presented as mean (SD), median (Md), and range. Categorical variables are presented as n (%).
aSample of participants reporting being unemployed, retired, or on medical leave.
bOnly assessed among participants who reported a full- or part-time job.
cNumber of participants reporting absences due to hemophilia. Only assessed among participants who were working/studying or going to
kindergarten.
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Table 3 Clinical characteristics of survey respondents
Adults
 18 y
N ¼ 106
Children/
Teenagers
10–17 y
N ¼ 21
Children (proxy version)
6–9 y
N ¼ 11
1–5 y
N ¼ 8
Type of hemophilia
Hemophilia A 89 (84.0%) 19 (90.5%) 10 (90.9%) 8 (100%)
Hemophilia B 17 (16.0%) 2 (9.5%) 1 (9.1%) 0
Hemophilia severity
Mild 13 (12.3%) 4 (19.0%) 0 1 (12.5%)
Moderate 33 (31.1%) 2 (9.5%) 3 (27.3%) 2 (25.0%)
Severe 60 (56.6%) 15 (71.4%) 8 (72.7%) 5 (62.5%)
Inhibitors
Yes 14 (13.2%) 1 (4.8%) 3 (27.3%) 2 (25.0%)
Does not know 27 (25.5%) 1 (4.8%) 1 (9.1%) 2 (25.0%)
Age at the time of diagnosis
During pregnancy/at birth 12 (11.3%) 3 (14.3%) 4 (36.4%) 5 (62.5%)
First year of life 40 (37.7%) 11 (52.4%) 5 (45.5%) 3 (37.5%)
1–5 y 21 (19.8%) 7 (33.3%) 2 (18.2%) 0
6–10 y 10 (9.4%) 0 0 –
 11 y 13 (12.3%) 0 0 –
Does not know 13 (12.3%) 0 0 0
Prophylaxis treatment 35 (33.0%) 16 (76.2%) 9 (81.8%) 4 (50.0%)
Type of factor concentrate
Plasma-derived 42 (39.6%) 5 (23.8%) 0 0
Recombinant 33 (31.1%) 11 (52.4%) 10 (90.9%) 6 (75.0%)
Bypassing agent 6 (5.7%) 1 (4.8%) 1 (9.1%) 1 (12.5%)
Does not know 14 (13.2%) 2 (9.5%) 0 0
Urgent hospital visits due to
hemophiliaa: yes
51 (48.1%) 13 (61.9%) 9 (81.8%) 4 (50.0%)
Number of visits 4.73 (4.44)
Md ¼ 3
range: 1–16
3.31 (2.14)
Md ¼ 2
range: 1–7
3.89 (3.26)
Md ¼ 2
range: 1–10
5.25 (3.76)
Md ¼ 5
range: 1–10
Hospitalization due to
hemophiliaa: yes
12 (11.3%) 4 (19.0%) 2 (18.2%) 2 (25.0%)
Number of days 12.58 (11.73)
Md ¼ 7.5
range: 4–39
5.67 (3.22)
Md ¼ 7
range: 2–8
1.5 (0.71)
Md ¼ 1.5
range: 1–2
5.0 (2.83)
Md ¼ 5
range: 3–7
Bleeding episodesa: yes 71 (67.0%) 15 (71.4%) 6 (54.5%) 4 (50.0%)
Number of bleeding episodes 14.94 (16.90)
Md ¼ 9
range: 1–84
4.53 (3.36)
Md ¼ 3
range: 1–12
5.0 (2.53)
Md ¼ 4.5
range: 2–8
6.0 (4.69)
Md ¼ 6.5
range: 1–10
Joint deterioration: yes 90 (84.9%) 12 (57.1%) 5 (45.5%) 2 (25.0%)
Number of affected joints 4.16 (2.55)
Md ¼ 4
range: 1–10
1.67 (1.16)
Md ¼ 1
range: 1–4
1.00 (1.00)
Md ¼ 1
range: 1–1
1.50 (0.71)
Md ¼ 1.5
range: 1–2
Most affected jointb: yes 72 (67.9%) 8 (38.1%) 3 (27.3%) 0
Knee 37 (51.4%) 1 (4.8%) 0 0
Ankle 29 (40.3%) 3 (14.3%) 2 (18.2%) 0
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relevant symptoms, 37 (36.7%) adults had clinically relevant
anxiety symptoms and 28 (27.2%) had signiﬁcant depression
symptoms (results not shown).
Illness Perceptions
The highest scores on IPQ-R, presented in ►Table 5, were
found on the “Timeline acute/chronic” dimension, both for
adults (M ¼ 12.95; SD ¼ 2.06) and children/teenagers
(M ¼ 12.25; SD ¼ 2.73), followed by the “Timeline cyclical”
dimension, which also scored high for both groups
(M ¼ 9.46; SD ¼ 2.65 for adults and M ¼ 9.85; SD ¼ 3.17
for children/teenagers).
Discussion
This was the ﬁrst nationwide hemophilia study conducted in
Portugal simultaneously covering sociodemographic and
clinical characteristics, as well as functional and psychoso-
cial variables.
Findings revealed a high prevalence of joint deterioration
and pain, with the ankles and the knees being the most
affected joints among all age groups. A signiﬁcant impact of
hemophilia on professional and economic levels was parti-
cularly evident.Moreover, signiﬁcant anxiety and depression
symptoms were found on 36.7% and 27.2% of adults,
Table 3 (Continued)
Adults
 18 y
N ¼ 106
Children/
Teenagers
10–17 y
N ¼ 21
Children (proxy version)
6–9 y
N ¼ 11
1–5 y
N ¼ 8
Elbow 14 (19.4%) 4 (19.0%) 1 (9.1) 0
Hip 6 (8.3%) 0 0 0
Shoulder 3 (4.17%) 0 0 0
Comorbidities
HIV 14 (13.5%) – – –
Hepatitis C 25 (24.0%) – – –
Pain due to hemophilia
In the previous year 82 (77.4%) 16 (76.2%) 9 (81.8%) 4 (50.0%)
Lasting over 3 months 65 (61.3%) 13 (61.9%) 6 (54.5%) 2 (25.0%)
More than once a week 43 (40.6%) 2 (9.5%) 1 (9.1%) 0
Pain with more impact N ¼ 82 N ¼ 16 N ¼ 9 N ¼ 4
Ankle 31 (37.8%) 7 (43.9%) 5 (55.5%) 1 (25.0%)
Knee 30 (36.30%) 2 (12.5%) 3 (33.3%) 0
Elbow 8 (97%) 3 (18.8%) 1 (11.1%) 1 (25.0%)
Shoulder 5 (6.1%) 0 0 0
Hip 5 (6.1%) 0 0 0
Others 3 (3.6%) 4 (25.1%) 0 2 (50.0%)
Pain durationc (months) 137.70 (136.46)
Md ¼ 96
range: 1–612
28.67 (38.03)
Md ¼ 6
range: 1–108
18.00 (22.03)
Md ¼ 8.5
range: 1–60
4.50 (0.71)
Md ¼ 4.50
range: 4–5
Pain frequencyc
Always present (a) 12 (14.6%) 0 0 0
Daily (b) 15 (18.3%) 0 0 0
Weekly (c) 12 (14.6%) 1 (6.3%) 0 0
Only during movement (d) 21 (25.6%) 4 (25.0%) 4 (44.4%) 0
Bleeding episodes only (e) 9 (11.0%) 6 (37.5%) 4 (44.4%) 4 (100%)
(c) þ (d) 2 (2.4%) 0 0 0
(c) þ (d) þ (e) 3 (3.7%) 0 0 0
(d) þ (e) 8 (9.8%) 5 (31.3%) 1 (11.1%) 0
Notes: Continuous variables are presented as mean (SD), median (Md), and range. Categorical variables are presented as n (%).
aData reporting to the previous year.
bMore than one response option is possible.
cConcerning the pain with more impact.
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respectively, and a belief of chronicity and symptoms unpre-
dictability was particularly prominent among adults and
children/teenagers. QoL was moderately affected among
adults but less affected in teenagers and children.
Socioeconomic Impact: Employment, Education, and
Economic Issues
In this study, 38 participants were currently not working
(unemployed, retired, or on medical leave), with approxi-
mately half of them claiming to be in that situation due to
hemophilia. Nevertheless, and concerning particularly
unemployment ﬁgures (7.5%), these were similar to current
global rates in Portugal (7.7%), showing that PWH in this
sample do not experience higher unemployment than the
general male population.22 Moreover, in this sample, among
the adults who were working, 50.9% declared an impact of
the disease on their professional activity. Regardless of the
professional status, 54.6% of adults further pointed to an
impact of hemophilia on their ﬁnancial income, underlining
the relevance of further exploring the individual and house-
hold economic burden of the disease, which has been an
overlooked subject in this ﬁeld. Parents of children with
hemophilia also reported missed days from work and an
impact of their child’s disease on their work life, similarly
with surveys conducted in other countries.23,24 School
absenteeism was also a relevant issue for teenagers and
children, since more than half of participants reported
missed days from school due to hemophilia. Despite the
lack of evidence of a negative impact of hemophilia on
educational status of PWH,25 Shapiro et al26 observed that
children with higher bleeding rates missed more days of
school and tended to have lower academic achievement.
Among adults, work/school absenceswere reported by 42.4%
participants and could last up to 293 days. These ﬁndings
unequivocally illustrate the negative impact of hemophilia
on work- or school-related activities, corroborating the data
from other surveys.13,23,24 However, it has already been
shown that prophylactic treatment can effectively reduce
the number of school and work absences,27,28 suggesting
that there might be some room for improvement in Portugal,
particularly among adults, who were less often submitted to
prophylactic regimens.
Since employment status and perceived impact of hemo-
philia have been shown to negatively inﬂuence clinical and
psychosocial outcomes,29 a special attention should be given
to these socioeconomic issues, by considering more ﬂexible
educational and employment policies that could beneﬁt
PWH. Interestingly, the number of participants with college
education (27.3%) in this current sample is similar to the
Portuguese general population (23.9% in the 25–64 age
group),30 showing that the impact of hemophilia is not
reﬂected on lower educational achievement. More robust
conclusions concerning this issue should be sought in future
studies, by comparing patients of different hemophilia
severities.
Clinical Characteristics: Bleeds, Prophylaxis, and Pain
To provide a comprehensive overview of hemophilia, people
of all disease severities were included in this survey. Dis-
tribution by type of hemophilia was in line with general
prevalence estimations, stating that hemophilia A affects 80
to 85% of the hemophilia population.5
Due to the occurrence of repeated joint bleeds, joint
deterioration is thehallmarkof hemophilia, posing a relevant
burden even in mild patients.31 According to other studies,24
a higher number of bleeding episodes were reported by
adults than by teenagers and children, illustrating the posi-
tive impact of early prophylaxis versus on-demand therapy
in decreasing the number of bleeds.4 This discrepancy among
age groups also occurred regarding the report of affected
joints.While 67.9% of adults reported at least a joint that was
most affected as a result of hemophilia, this outcomewas less
pointed out by the 10 to 17 (38.1%) and the 6 to 9 (27.3%)
years old groups. Nonetheless, the number of reported
bleeds and presence of affected joints in the younger age
groups is still very signiﬁcant, considering that most
Table 4 Physical activity practice and aspirational sports of survey respondents
Adults
 18 y (N ¼ 106)
Children/Teenagers
10–17 y (N ¼ 21)
Children (proxy version)
6–9 y (N ¼ 11) 1–5 y (N ¼ 8)
Regularly: 29 (27.4%) Regularly: 12 (57.1%) Regularly: 9 (81.8%) Regularly: 4 (50.0%)
1. Swimming 16 1. Swimming 5 1. Swimming 7 1. Swimming 4
2. Walking 5 2. Football 3 2. Hockey 1 2. Football 1
3. Cycle 3 3. Dance
3. Gym
2
2
3. Dance 1 – –
Aspirational
sport:
61 (57.5%) Aspirational
sport:
15 (71.4%) Aspirational
sport:
9 (81.8%) Aspirational
sport:
1 (12.5%)
1. Football 24 1. Football 5 1. Football 8 1. Football 1
2. Cycle 12 2. Martial
arts
3 2. Swimming 1 – –
3. Martial
arts
5 3. Basketball
3. Handball
2
2
– – – –
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participants are under prophylaxis. Though these data could
be partially explained by some over reporting from parents
in the proxy versions, future studies should seek to clarify
this issue to effectively prevent the development of debilitat-
ing hemophilic arthropathy in these age groups.
In the current study, 33% of adults reported to be under
prophylaxis treatment. Theseﬁgures are notably higher than
results regarding countries such as Algeria (0%), China (4%),
and Argentina (14%), though below other countries such as
France (58%), Italy (56%), Germany (48%), and Canada (48%),
according to the HERO study,32 an international survey
conducted among PWH in several countries. However,
regarding these ﬁgures, hemophilia severity was not taken
into account and thus caution must be applied when
Table 5 Psychosocial and functionality variables among survey respondents
Measure (range) Adults
 18 y
N ¼ 106
Children/Teenagers
10–17 y
N ¼ 21
Children (proxy version)
6–9 y
N ¼ 11
M (SD) Min-max M (SD) Min-max M (SD) Min-max
A36 Hemoﬁlia-QoL
Global score (0–144) 96.45 (27.33) 31–144 – – – –
Physical health (0–32) 21.57 (6.70) 7–32 – – – –
Daily activities (0–16) 9.99 (5.13) 0–16 – – – –
Joint damage (0–12) 6.64 (2.99) 0–12 – – – –
Pain (0–8) 4.61 (2.23) 0–8 – – – –
Treatment satisfaction (0–8) 5.98 (1.64) 1–8 – – – –
Treatment difﬁculties (0–16) 11.74 (3.67) 0–16 – – – –
Emotional functioning (0–20) 12.11 (5.21) 0–20 – – – –
Mental health (0–12) 7.85 (2.97) 0–12 – – – –
Relationships and social
activity (0–20)
15.18 (4.85) 0–20 – – – –
CHO-KLAT (0–100) – – 75.63 (12.06) 54–93 76.32 (11.89) 52–87
HAL/PedHAL (0–100)
Global score 66.29 (25.47) 5–100 92.35 (11.98) 54–100 86.28 (18.66) 37–100
Lying/sitting/kneeling/
standing
60.53 (28.72) 3–100 90.76 (15.16) 46–100 86.63 (19.73) 34–100
Functions of the legs 55.92 (30.21) 0–100 89.30 (19.39) 20–100 78.80 (20.26) 44–100
Functions of the arms 69.63 (27.51) 0–100 94.60 (8.53) 77–100 91.52 (20.99) 30–100
Use of transportation 68.94 (29.55) 13–100 94.13 (18.37) 20–100 88.48 (20.02) 33–100
Self-care 80.69 (22.89) 8–100 96.51 (8.51) 67–100 88.91 (21.79) 28–100
Household tasks 74.76 (25.45) 0–100 96.83 (7.19) 80–100 90.30 (20.52) 33–100
Leisure activities and sports 70.49 (25.52) 0–100 90.04 (13.61) 60–100 85.71 (21.32) 42–100
PROMIS (4–20)
Anxiety 7.02 (2.95) 4–19 – – – –
Depression 6.23 (3.26) 4–20 – – – –
IPQ-R (3–15)
Timeline acute/chronic 12.95 (2.06) 7–15 12.25 (2.73) 6–15 – –
Timeline cyclical 9.46 (2.65) 3–15 9.85 (3.17) 3–15 – –
Consequences 8.72 (3.12) 3–15 7.70 (2.54) 4–14 – –
Personal control 7.71 (2.46) 3–15 8.15 (2.11) 4–14 – –
Treatment control 6.79 (2.09) 3–15 5.10 (1.55) 3–7 – –
Illness coherence 5.69 (2.42) 3–15 6.25 (2.45) 3–11 – –
Emotional representation 6.62 (3.22) 3–15 7.50 (4.19) 3–15 – –
Abbreviations: CHO-KLAT, Canadian Haemophilia Outcomes-Kids' Life Assessment Tool; HAL, Haemophilia Activities List; IPQ-R, Illness Perception
Questionnaire-Revised; PedHAL, Pediatric Haemophilia Activities List; PROMIS, Patient-Reported Outcomes Measurement Information System.
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establishing comparisons. For instance, if only the severe
cases of current adult sample were considered, prophylaxis
would rise to 55%. Nevertheless, and according to a recent
study on prophylaxis access among severe PWH,33 these
Portuguese ﬁgures are still below other countries, such as
Belgium, Ireland, and the Netherlands, wherein 76 to 100% of
adults have access to prophylaxis. Concerning Portuguese
children and teenagers, access to prophylaxis is higher when
compared with adults, covering 56 to 100% of them, which
matches the practices of developed countries like Belgium,
Finland, Ireland, or Norway, for instance.33
Concerning pain, current ﬁndings conﬁrm that this is a
critical aspect of hemophilia, by revealing a high prevalence
of pain at all age levels. Though comparisons of pain reports
across studies are constrained by the variety of methods
used, this is in accordance with the high prevalence of pain
among PWH reported by other studies.24,34 Present ﬁndings
further highlighted that pain constitutes part of the daily life
of amajority of Portuguese PWH, since adults revealed a high
duration and frequency of pain, which could last for more
than 50 years and occur on a daily or weekly basis or even
constantly. Pain experience in hemophilia is associated with
worst psychological functioning, functional disability, and
diminished QoL, additionally increasing the burden of the
disease itself.34,35 The development of evidence-based pain
management guidelines and effective practices is therefore
imperative and must be a priority in hemophilia care. In this
scope, three issues are crucial and should be considered: a
closer collaboration between hemophilia clinicians and pain
specialists; the implementation of effective pain control
strategies that could include, beyond pharmacological, non-
pharmacological approaches, namely, psychological strate-
gies which cost-effectiveness has been shown across distinct
diseases36 despite its underuse among PWH; and, ﬁnally, the
recognition of pain as a critical hemophilia issue by hemo-
philia health care providers.
Physical Activity and Sports
Physical activity has many beneﬁts and is recommended for
PWH as a means of promoting physical ﬁtness, healthy
neuromuscular development, and social and psychological
well-being,5 being even associated with a decrease in pain
perception and in factor replacement consumption.37
A high frequency of physical activity among PWH has been
reported elsewhere;38 however, only 27.4% of adults in this
Portuguesesampledeclaredpracticing sports regularly. In fact,
these resultsmatch the Portuguese global pattern,with recent
reports indicating that 64% of the general population never
exercise or play sports.39 Nonetheless, the hypothesis can be
made that, in some cases, low physical activity frequency is
explainedby fear of bleeding episodes, underlining theneed to
promote knowledge about the role of physical activity among
PWH, as well as speciﬁc recommendations and protective
measures. Actually, in a recent study,40 the main reasons
indicated by PWH for not doing any sport were their physical
condition and fear of hurting themselves.
Among younger PWH, about half in the 10 to 17 (57.1%)
and 1 to 5 (50%) years old group, and most in the 6 to 9 years
old group (81.8%), declared to practice physical activity
regularly. This corroborates other ﬁndings showing a high
proportion of children with hemophilia practicing regular
sports,38 with activity levels comparable to healthy peers.41
Similar to other studies with PWH, the most desired activity
was football, in all age ranges,24 and the most commonly
practiced sport was swimming, which is generally recom-
mended to PWH as a low-impact sport.42 Concerning this
issue, the most important is to implement strategies focused
on fostering regular engagement in physical activity among
PWH, promoting education about its beneﬁts and potential
risks, as well as timely and adequate measures to deal with
eventual injuries.5,40,42
Quality of Life and Functionality
Studies generally report diminished QoL among PWH9,10,43
even inmild patients,44 though some studies account for QoL
scores in PWH comparable to the general population when
considering speciﬁc age groups45 or only mild/moderate
patients.46 In the current study, QoL scores of Portuguese
adults fall in the 50 to 75 percentile, translating a moderate
level of health-related QoL in all dimensions considered. In
fact, these results are in accordance with QoL scores
described in a culturally similar sample from Spain, using
the same questionnaire.15 Interestingly, an investigation in
Iran,47 also using this questionnaire, revealed lower mean
scores, with some dimension scores falling below the 50%
percentile and the global QoL percentile being 49%. A pos-
sible explanation for this might be that Iran is a developing
country, likely exhibiting a limited access to prophylaxis,48
along with more social and economic constraints which
potentially moderate negatively the impact of the disease
on QoL. In addition, these comparisons also support the
positive impact of prophylaxis on improving QoL6
Among children and adolescents with hemophilia, QoL is
generally less affected,49,50 albeit decreased QoL scores have
also been reported when compared with healthy peers.51 In
the present study, CHO-KLAT mean scores are slightly lower
than those reported in the Netherlands49 and Canada,50
higher than those found in Brazil52 and Germany,49 but
broadly consistent with those obtained in France, United
Kingdom, and Spain.49
Furthermore, regarding functionality assessment, it was
concluded that “Functions of the legs” was the lowest scoring
dimension in all age ranges, congruentlywith theankles and the
knees being reported as most affected joints and painful loca-
tions, and matching other studies regarding functionality.18,34
Emotional Distress and Illness Perceptions
Concerning emotional distress, 36.7 and 27.2% of adults
revealed clinically relevant anxiety and depression symp-
toms, respectively, in accordance with other studies among
PWH describing rates of 22 to 37% of participants with
signiﬁcant distress.24,29,53 Regarding these ﬁgures, it is
important to highlight the well-known inﬂuence of psycho-
logical factors on both pain experience and QoL in PWH.35
Indeed, it waspreviously noted that changes inQoL arebetter
explained by psychosocial, rather than clinical predictors,25
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highlighting psychosocial health as a priority target in the
improvement of health status and QoL in PWH.12,24 An
important implication stemming from this is that compre-
hensive care teams should bemultidisciplinary and include a
complete assessment of psychosocial status and psychologi-
cal support, contributing to an integrated disease manage-
ment plan. Furthermore, since psychological factors are
amenable to change or to active management through
psychological interventions, there is a need to advance
knowledge in this ﬁeld, through the implementation of
interventions targeting psychological aspects of PWH,which
effectiveness should be evaluated.
Besides emotional characterization, the evaluation of ill-
ness beliefs was an innovative feature of this survey. Both
adults andchildren/teenagershadthehighest scoreson “Time-
line acute/chronic” dimension, indicating that participants
had the perception of this being a lifelong disease, deemed
as chronic and permanent rather than acute or temporary.
Moreover, the second highest score on “Timeline cyclical”
dimension shows how participants consider hemophilia
symptomatology as unpredictable, unstable, and hard to
manage. Given the impact of illness beliefs on treatment
adherence by PWH,54 this result underlines the relevance of
developing and implementing educative programs that pro-
mote knowledge about hemophilia and its symptoms, along
with the induction of positive but realistic expectancies on the
effect of treatments. Since hemophilia is actually a chronic
lifelong disease, yielding unpredictable symptoms, psychoso-
cial interventions in thisﬁeld shouldpromote acceptanceasan
adaptive coping disease mechanism and a more positive view
of the expectations concerning hemophilia.
Limitations
This study has some limitations that should be addressed.
The representativeness of the participants was not con-
trolled for and the exclusive inclusion of PWH registered
on a patients’ organization may represent a bias on study
sampling. Simultaneously, the low response rate may be
responsible for some nonresponse bias that was not con-
trolled for, as there was no information available concerning
the characteristics of nonparticipants, except for age.
Furthermore, it is also likely that people who participated
present distinct psychosocial characteristics, related to dis-
ease acceptance, coping strategies, or emotional responses
(e.g., sadness, anger), when compared with nonparticipants.
Hence, the likelihood of not having captured the whole
Portuguese hemophilia picture should be taken into account.
Moreover, some of the data could not be directly com-
pared with other investigations due to relevant variations in
clinical features of patients included and the fact that the
distribution of variables of interest in those studies is some-
times only described in terms of type of hemophilia, factor
activity level, treatment regimen, age, or other characteris-
tics, which confound comparative analysis. Given the global
aim of providing a comprehensive description of PWH, the
current resultswere not presented by severity of hemophilia,
which may underscore some characteristics of more severe
patients, which were a majority in this sample.
Conclusion
This survey provided the most complete characterization of
Portuguese PWH to date, uncovering several intervention
needs that are critical to improve well-being and QoL. This
allows for a broader and deeper understanding of life with
hemophilia and thus contributes to evidence that can be used
in providing more effective patient care among PWH. Parti-
cularly, this survey represents the ﬁrst assessment of psy-
chosocial variables among PWH in Portugal, yielding reliable
data to inform clinical practice that is not derived from
conclusions from other countries. Globally, the results
reported on clinical and psychosocial variables are in accor-
dance with studies from other countries and with what
might be expected in a developed country with a strong
national health care service. Current ﬁndings contributed to
further underline the relevance of issues that have been
receiving increased attention in the hemophilia ﬁeld, parti-
cularly the need to improve pain assessment and manage-
ment and expand psychosocial care. In fact, according to a
recent survey of European countries, pain management and
social/psychological support are still among the least avail-
able specialty services in hemophilia care and, in Portugal,
there was even a reported decrease in access to social and
psychological support in recent years.29
Further detailed analysis of the data are warranted and
should consider the results by hemophilia type, severity, and
presence of inhibitors, to achieve a deeper understanding of
the hemophilia experience of Portuguese patients and better
contribute for the improvement of integrated care. Long-
itudinal studies will also be important to help determine the
predictors of disease course and adjustment to tailor inter-
ventions that promote QoL and well-being.
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